cbdMD
YCBD
10 hedge funds and large institutions have $2.71M invested in cbdMD in 2018 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 2 closing their positions.
250% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 2
190% more capital invested
Capital invested by funds: $936K → $2.71M (+$1.78M)
100% more funds holding
Funds holding: 5 → 10 (+5)
0% more ownership
Funds ownership: 0.01% → 0.01% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$1.25M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$436K |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$232K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$152K |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$148K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$11K |
| 2 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
-$2K |
YCBD Hedge Fund Activity: Q4 2018 in Review
10 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in cbdMD (YCBD) for Q4 2018, worth a combined $2.71M — up 190% from $936K a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new YCBD positions and 2 closed out — a net gain of 5 holders — while 3 added to existing stakes and 0 trimmed.
The largest buyer was BlackRock, adding an estimated $1.25M. The largest seller was Deutsche Bank, exiting entirely with an estimated $11K sold.
- 10 institutional investors held cbdMD (YCBD) as of Q4 2018, up from 5 in Q3 2018.
- Funds reported $2.71M of cbdMD stock for Q4 2018, up 190% quarter-over-quarter.
- 7 funds opened new cbdMD positions in Q4 2018 and 2 closed out, a net change of +5 holders.
- The largest cbdMD buyer in Q4 2018 was BlackRock, an estimated $1.25M added.
- The largest cbdMD seller in Q4 2018 was Deutsche Bank, an estimated $11K sold.
Based on aggregated 13F filings for Q4 2018.